Results 111 to 120 of about 29,765 (156)

Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design. [PDF]

Int J Chron Obstruct Pulmon Dis, 2016
Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H.   +8 more
europepmc   +1 more source

Changing patterns of asthma medication use related to US Food and Drug Administration long-acting β2-agonist regulation from 2005-2011. [PDF]

J Allergy Clin Immunol, 2016
Butler MG, Zhou EH, Zhang F, Wu YT, Wu AC, Levenson MS, Wu P, Seymour S, Toh S, Iyer A, Iyasu S, Baker MA.   +11 more
europepmc   +1 more source

The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study. [PDF]

NPJ Prim Care Respir Med, 2016
Sousa AR, Riley JH, Church A, Zhu CQ, Punekar YS, Fahy WA.   +5 more
europepmc   +1 more source

Long-acting muscarinic antagonist and long-acting β₂-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative review. [PDF]

Ther Adv Respir Dis
Buhl R, Miravitlles M, Anzueto A, Brunton S.   +3 more
europepmc   +1 more source

Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease. [PDF]

Int J Chron Obstruct Pulmon Dis, 2015
Ichinose M, Takizawa A, Izumoto T, Tadayasu Y, Hamilton AL, Kunz C, Fukuchi Y.   +6 more
europepmc   +1 more source

The risk factors of future exacerbations and treatment responses among different inhalation therapies of patients with preserved ratio impaired spirometry. [PDF]

J Glob Health
Cao J, Sun T, Yang H, Zhou L, Shen Q, Lin L, Li T, Zhang P, Zeng Y, Chen P, Song Q, Lei S, Li J.   +12 more
europepmc   +1 more source

Signaling Bias as a Framework for Therapeutically Relevant Orthosteric Agonists: The β₂ Adrenergic Receptor Paradigm. [PDF]

Biochemistry
Georgiou K, Kolocouris A.
europepmc   +1 more source

Reported use of anti-asthmatic medication in doping control forms from 2015 to 2019 - mapping retrospective data. [PDF]

Front Sports Act Living
Kojen AJ, Halvorsen T, Gjelstad A, Larsen S, Lauritzen F, Stensrud T.   +5 more
europepmc   +1 more source

Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same? [PDF]

Tuberc Respir Dis (Seoul), 2018
Miravitlles M, Baek S, Vithlani V, Lad R.   +3 more
europepmc   +1 more source

Effects of ICS + LABA Combination Therapy on Asthma Control: An Observational Study in Real-World Settings. [PDF]

Ther Clin Risk Manag
Han P, Wang L.
europepmc   +1 more source